LUVANTAS
Live / Registered — Registered (as of 20 Aug 2024)
What this means for you
Registered since 20 Aug 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97715850
- Registration number
- 7477829
- Mark type
- Stylized text
- Filed
- 13 Dec 2022
- Published for opposition
- 04 Jun 2024
- Registered
- 20 Aug 2024
- Attorney of record
- Mark J. Liss
Goods and services
- Class 005 — Pharmaceuticals: Implantable medicines for treating neurological disorders and muscle dystonia; implantable antiaging medicines, namely, botulinum toxin for medical use for treatment of facial wrinkles; pharmaceuticals containing botulinum toxin for medical use for use in the treatment of glabellar lines, forehead wrinkles, lateral canthal line, migraine headache, overactive bladder, urge incontinence, prostate disorder, cervical dystonia, spasticity, muscle dystonia, blepharospasm, hyperhidrosis, strabismus, excessive eye blinking, neuropathy pain and pelvic pain; pharmaceutical syringes prefilled with medical botulinum toxin as the main ingredient for medical use for use in the treatment of glabellar lines, forehead wrinkles, lateral canthal line, migraine headache, overactive bladder, urge incontinence, prostate disorder, cervical dystonia, spasticity, muscle dystonia, blepharospasm, hyperhidrosis, strabismus, excessive eye blinking, neuropathy pain and pelvic pain
Owner
- Medytox Inc., Chungcheongbuk-do, KR
- Medytox Inc., Chungcheongbuk-do, KR
- Medytox Inc., Chungcheongbuk-do, KR
Prosecution history
- 20 Aug 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 20 Aug 2024 — REGISTERED-PRINCIPAL REGISTER
- 04 Jun 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 04 Jun 2024 — PUBLISHED FOR OPPOSITION
- 29 May 2024 — ATTORNEY REVIEW COMPLETED
- 29 May 2024 — ATTORNEY REVIEW COMPLETED
- 15 May 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 May 2024 — CASE RETURNED TO EXAMINATION
- 02 May 2024 — NOTICE OF ALLOWANCE CANCELLED
- 25 Apr 2024 — JURISDICTION RESTORED TO EXAMINING ATTORNEY
- 25 Apr 2024 — PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
- 23 Apr 2024 — ASSIGNED TO PETITION STAFF
- 29 Mar 2024 — TEAS PETITION TO AMEND BASIS RECEIVED
- 23 Jan 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Jan 2024 — SOU EXTENSION 1 GRANTED